Written Question·Department of Health and Social Care·UIN HL4917
Tabled: 4 November 2026
Question
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 2 November (HL4193), whether she intends to publish the safety evaluation report for vortioxetine submitted by a marketing authorisation holder that is currently being as